VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,955,250 | -8.4% | 1,425,000 | -13.1% | 1.22% | -3.6% |
| Q1 2023 | $38,167,454 | +77.4% | 1,640,200 | +93.0% | 1.27% | +171.9% |
| Q4 2022 | $21,513,500 | +11.4% | 850,000 | +12.1% | 0.47% | +5.2% |
| Q2 2022 | $19,312,000 | -3.7% | 758,211 | -2.8% | 0.44% | +6.0% |
| Q1 2022 | $20,062,000 | -31.6% | 780,000 | +11.4% | 0.42% | -32.8% |
| Q4 2021 | $29,309,000 | +30.8% | 700,000 | +35.9% | 0.62% | +25.2% |
| Q3 2021 | $22,413,000 | +192.6% | 515,000 | +217.9% | 0.50% | +140.1% |
| Q2 2021 | $7,659,000 | -69.9% | 162,000 | -73.9% | 0.21% | -87.3% |
| Q2 2020 | $25,426,000 | – | 620,600 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |